---
document_datetime: 2023-09-21 17:34:07
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/rebif-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: rebif-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 2.9457945
conversion_datetime: 2025-12-21 19:24:40.410635
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

## For procedures finalised after 1 March 2004 please refer to module 8B.

- The MAH submitted on 20 August 1998 an application to obtain a marketing authorisation in accordance  with  Annex  II  of  Commission  Regulation  (EC)  No  542/95  of  10  March  1995 (part vi) as amended, falling within the scope of Part A of the Annex of the Council regulation EC No.  2309/93.  The  procedure  started  on  21  August  1998,  supplementary  information  was supplied  by  the  MAH  on  11  December  1998,  the  Applicant  gave  oral  explanations  on  16 December 1998, and a positive opinion was adopted by the CPMP on 16 December 1998. The European Commission granted a Commission Decision on 29 March 1999 (EMEA/H/C/136/X/01).
- The  MAH submitted  on  20  August  1998  an  application  for  a  Type  II  variation,  pursuant  to Article 6 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply for a change of the SPC and PIL. The procedure started on 21 August 1998 and a positive opinion was adopted by the CPMP on 22 October 1998. The European Commission granted a Commission Decision on 1 February 1999 (EMEA/H/C/136/II/02).
- Pursuant to Article 13(2) of Council Regulation (EEC) No 2309/93 and part 4G of Annex to Council  Directive  75/318/EEC,  the  MAH  provided  in  the  foreseen  timeframe  the  reports  of ongoing studies according to the specific obligations stated in the Annex II of the Commission Decision. The MAH submitted to the EMEA the documentation, which formed the basis of the first  annual  re-assessment  of  the  benefit/risk  profile  for  Rebif.  The  Rapporteur's  annual assessment report was circulated to all CPMP Members on 9 June 1999. During the June 1999 CPMP plenary meeting, the CPMP agreed with the Rapporteur's assessment report and adopted a  positive  opinion on the annual re-assessment of the specific obligations and the benefit/risk ratio,  stating  that  no  amendments  of  Annexes  I  and  III  to  the  Community  Marketing Authorisation are necessary and that the marketing authorisation should remain under exceptional  circumstances.  The  European  Commission  granted  a  Commission  Decision  on 3 December 1999 (EMEA/H/C/136/S/03).
- The MAH submitted on 10 May 1999 an application for a Type I variation No 13 of Annex I to the regulation, pursuant to Article 4 of  Commission  Regulation  (EC)  No. 542/95 of 10 March 1995  as  amended,  in  order  to  apply  for  a  change  (scale-up)  of  the  manufacturing process.  The  procedure  started  on  21  May  1999  and  a  positive  opinion  was  adopted  by  the CPMP  on 28 July 1999 (EMEA/H/C/136/I/05). The European Commission granted a Commission Decision on 3 August 1999.
- The MAH submitted on 10 May 1999 an application for a Type I variation No 12 of Annex I to the regulation, pursuant to Article 4 of  Commission  Regulation  (EC)  No. 542/95 of 10 March 1995 as amended, in order to apply for minor changes to the manufacturing process. The procedure started on 21 May 1999, supplementary information was supplied by the MAH on  19 July  1999,  and  a  positive  opinion  was  adopted  by  the  CPMP  on  22  September  1999 (EMEA/H/C/136/I/06). The European Commission  granted a Commission  Decision on 5 October 1999.
- The MAH submitted on 25 August 1999 an application for a variation, pursuant to Article 10(3) of  Council  Directive  No.  92/27/EEC  of  31  March  1992,  as  amended  in  order  to  apply  for  a change  in  the  PIL,  not  connected  with  the  SPC.  The  procedure  started  on  31  August,  and  a positive  opinion  was  adopted  by  the  CPMP  on  7  October  1999  (EMEA/H/C/136/N/07).  The European Commission granted a Commission Decision on 14 December 1999.
- The MAH submitted on 1 September 1999 an application for a Type I variation, pursuant to Article 4 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply  for  an  extension  of  the  shelf  life  from  12-24  months.  The  procedure  started  on 7 September  1999,  and  a  positive  opinion  was  adopted  by  the  CPMP  on  7  October  1999

<div style=\"page-break-after: always\"></div>

(EMEA/H/C/136/I/08). The European Commission  granted a Commission  Decision on 14 December 1999.

- The MAH submitted on 9 September 1999 an application for a Type II variation, pursuant to Article 6 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply for changes to active substance specifications and test methods. The procedure started on 23 September 1999, and a positive opinion was adopted by the CPMP on 18 November 1999 (EMEA/H/C/136/II/09).  The  European  Commission  granted  a  Commission  Decision  on 2 December 1999.
- The  MAH submitted  on  20  October  1999  an  application  for  a  Type  I  variation,  pursuant  to Article 4 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply for a change of name of the manufacturer responsible for batch release. The procedure started on 25 October 1999, and a positive opinion  was adopted by  the  CPMP  on 12 November 1999 (EMEA/H/C/136/I/10). The European Commission granted a Commission Decision on 20 January 2000.
- The MAH submitted on 11 February 2000 an application for a Type I variation, pursuant to Article 4 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply  for  a  change  of  to  the  manufacturing  process  of  the  active  substance.  The  procedure started on 18 February  2000,  and a  positive  opinion  was  adopted  by  the  CPMP  on 16 March 2000.  (EMEA/H/C/136/I/12).  The  European  Commission  granted  a  Commission Decision on 11 April 2000.
- The MAH submitted on 16 May 2000 an application for a Type II variation, pursuant to Article 6 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply for  changes  in  the  SPC  and  PL,  based  on  the  results  of  the  extension  study  in  RRMS.  The procedure  started  on  26  May  2000,  and  a  positive  opinion  was  adopted  by  the  CPMP  on 19 October  2000  (EMEA/H/C/136/II/13).  The  European  Commission  granted  a  Commission Decision on 22 January 2001.
- Pursuant to Article 13(2) of Council Regulation (EEC) No 2309/93 and part 4G of Annex to Council  Directive  75/318/EEC,  the  MAH  provided  in  the  foreseen  timeframe  the  reports  of ongoing studies according to the specific obligations stated in the Annex II of the Commission Decision. The MAH submitted to the EMEA the documentation, which formed the basis of the second  annual  re-assessment  of  the  benefit/risk  profile  for  Rebif.  The  Rapporteur's  annual assessment report was circulated to all CPMP Members on 26 June 2000. During the July 2000 CPMP plenary meeting, the CPMP agreed with the Rapporteur's assessment report and adopted a  positive  opinion on the annual re-assessment of the specific obligations and the benefit/risk ratio,  stating  that  no  amendments  of  Annexes  I  and  III  to  the  Community  Marketing Authorisation are necessary. Since all specific obligations stated in Annex II of the Commission Decision  have  been  fulfilled,  the  CPMP  recommended  that  the  Marketing  Authorisation  for Rebif was released from the status 'under exceptional circumstances'(EMEA/H/C/136/S/14).
- The MAH submitted on 13 July 2000 an application for a Type I variation No 12 of Annex I to the regulation, pursuant to Article 4 of Commission regulation (EC) No. 542/95 of 10 March 1995,  as  amended,  in  order  to  apply  for  minor  changes  to  the  active  substance  production process.  The  procedure  started  on  28  July  2000,  and  a  positive  opinion  was  adopted  by  the CPMP  on  21  September  2000  (EMEA/H/C/136/I/16).  The  European  Commission  granted  a Commission Decision on 16 October 2000.
- The MAH submitted on 13 July 2000 an application for a Type II variation, pursuant to Article 6 of Commission regulation (EC) No. 542/95 of 10 March 1995, as amended, in order to apply for an amendment in the specifications of the active substance. The procedure started on 28 July 2000, and a positive opinion was adopted by the CPMP  on 21 September 2000 (EMEA/H/C/136/II/17).  The  European  Commission  granted  a  Commission  Decision  on 16 October 2000.

<div style=\"page-break-after: always\"></div>

- The MAH submitted on 28 July 2000 an application for a Notification of a Type I variation, pursuant  to  Article  4  of  Commission  regulation  (EC)  No.  542/95  of  10  March  1995,  as amended, in order to apply for minor changes to the active substance production process. The procedure started on 4 August 2000, and a positive opinion was signed on 1 September 2000 (EMEA/H/C/136/I/18). The European Commission  granted a Commission  Decision on 12 September 2000.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                            | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|--------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Extension of Indication                                                                          | II/11                | II                       | 25.07.01                            | 21.11.01                                 |
| Change in or addition of manufacturer(s) of active substance                                     | I/15                 | I                        | 14.12.00                            | 20.03.01                                 |
| Change in or addition of manufacturing site(s) por part or all of the manufacturing process      | I/II/19              | I/II                     | 14.12.00                            | 20.12.00                                 |
| Changes to comply with supplements to pharmacopoeias                                             | I/20                 | I                        | 28.02.01                            | 13.03.01                                 |
| Change in storage conditions                                                                     | I/21                 | I                        | 11.06.01                            |                                          |
| Change(s) to the manufacturing process for the active substance                                  | X-22                 | X                        | 17.10.02                            | 16.01.03                                 |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | N-24                 | N                        | 21.08.01                            | 03.10.01                                 |
| Change in supplier of an intermediate compound used in manufacture of the active substance       | I/25                 | I                        | 09.08.01                            | 07.09.01                                 |
| Change in the name and/or address of the marketing authorisation holder                          | I/26                 | I                        | 26.07.01                            | 18.09.01                                 |
| Change in or addition of manufacturing site(s) for part or all of the manufacturing process      | I/27                 | I                        | 17.08.01                            | 07.09.01                                 |
| Extension of shelf-life or retest period of the active substance                                 | I/28                 | I                        | 21.09.01                            |                                          |
| Change(s) to the manufacturing process for the active substance                                  | II/29                | II                       | 15.11.01                            | 28.11.01                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                 | II/30                | II                       |                                     | 17.05.02                                 |
| Change in the batch size of finished product                                                     | I/31                 | I                        | 01.02.02                            | 11.02.02                                 |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | N/32                 | N                        | 11.03.02                            | 02.04.02                                 |
| Change(s) to the test method(s) and/or specifications for the finished product                   | II/33                | II                       | 25.07.02                            | 31.07.02                                 |
| Change in the procedure of active substance                                                      | I/34                 | I                        | 25.07.02                            | 31.07.02                                 |
| Change in the supplier of an intermediate compound used in manufacture of active substance       | I/35                 | I                        | 22.08.02                            | 10.09.02                                 |
| Minor change of manufacturing process of the active substance                                    | I/36                 | I                        | 22.08.02                            | 10.09.02                                 |
| Change in specification of starting material/intermediate used in manuf. of the active substance | I/37                 | I                        | 11.12.02                            | 13.12.02                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                 | II/38                | II                       | 19.03.03                            | 25.06.03                                 |
| Minor change in the package leaflet not connected with the SPC                                   | N/39                 | N                        | 27.01.03                            | 04.03.03                                 |
| Renewal                                                                                          | R/40                 | R                        | 19.03.03                            | 04.06.03                                 |
| Change(s) to the test method(s) and/or specifications for the active substance                   | II/42                | II                       | 22.05.03                            | 27.05.03                                 |
| Change in container shape                                                                        | I/43                 | I                        | 20.08.03                            | 18.09.03                                 |
| Change(s) to the test method(s) and/or specifications for the active substance                   | II/44                | II                       | 22.10.03                            | 30.10.03                                 |
| Replacement/add. of manufacturing site: Secondary packaging site                                 | I/45                 | I                        | 01.12.03                            | -                                        |
| Change in in-process controls applied during the manufacture of the product                      | I/46                 | I                        | 01.12.03                            | -                                        |
| Change in in-process controls applied during the manufacture of the product                      | I/48                 | I                        | 20.10.03                            | -                                        |
| Update of Summary of Product Characteristics and Package Leaflet                                 | II/49                | II                       | 17.12.03                            | 23.02.04                                 |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.